Table 1 Characteristics of 17 patients with combined anti-GBM disease and membranous nephropathy.
Case Number [ref #] | Age/Sex | Initial serum creatinine (mg/dL) | Clinical presentation | Treatment | Outcome |
|---|---|---|---|---|---|
1 [2] | 49/M | 18.0 | Edema | Steroids | Died |
2 [3] | 53/M | 13.0 | Edema | Steroids, azathioprine | Hemodialysis |
3 [3] | 44/M | 3.1 | Edema | Steroids | Hemodialysis |
4 [4] | 20/F | 1.2 | Cough, syncope | None | Survived |
5 [5] | 19/F | 10.5 | Hemoptysis | Steroids (p)*, azathioprine, nephrectomy | Hemodialysis |
6 [6] | 25/M | 2.1 | Hemoptysis | Steroids, PP** | Died |
7 [7] | 65/M | 4.0 | Edema | Steroids, PP, cyclophosphamide | Died |
8 [8] | 20/M | 3.0 | Fever, sore throat, lumbar pain | Steroids, PP | Survived |
9 [9] | 54/M | 1.1 | Cough, arthralgia | Steroids, PP | Hemodialysis |
10 [10] | 60/M | 19.5 | Fatigue, anorexia, edema | Steroids (p), PP | Hemodialysis |
11 [11] | 57/not reported | 11.8 | Fatigue, hemoptysis | Steroids (p), PP, cyclophosphamide | Hemodialysis |
12 [12] | 50/M | 0.7 | Edema | Steroids (p), PP, cyclophosphamide | Survived |
13 [13] | 50/F | 8.9 | Edema, nausea | Steroids (p), PP | Hemodialysis |
14 [14] | 54/F | 8.9 | Hematuria | Steroids, PP | Hemodialysis |
15 [15] | 49/M | 7.3 | Hematuria, flank pain, fatigue | Steroids, PP, cyclophosphamide | Hemodialysis |
16 [16] | 50/F | 11.6 | Edema | Steroids, PP, cyclophosphamide | Hemodialysis |
17 (present case) | 59/M | 25.0 | Fatigue, oliguria, nausea | Steroids, PP, cyclophosphamide | Hemodialysis |